← All trials
NCT04377399
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 10, 2018
- Primary completion
- Jun 20, 2019
- Completion date
- Jan 25, 2020
- First posted
- May 6, 2020
- Last posted
- May 6, 2020
- Enrollment
- 68
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Government of RussiaLead sponsor
- Almazov National Medical Research CentreOverall official - principal investigator
- Tameside Hospital NHS Foundation TrustCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.